PT - JOURNAL ARTICLE AU - de Lemos Menezes, Pedro AU - Garner, David M. AU - Valenti, Vitor E. TI - BRAZIL IS PROJECTED TO BE THE NEXT GLOBAL COVID-19 PANDEMIC EPICENTER AID - 10.1101/2020.04.28.20083675 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.28.20083675 4099 - http://medrxiv.org/content/early/2020/05/05/2020.04.28.20083675.short 4100 - http://medrxiv.org/content/early/2020/05/05/2020.04.28.20083675.full AB - Coronavirus disease 2019 (COVID-19) is a disease triggered by SARS-CoV-2 infection, which is related in the most recent pandemic situation, significantly affecting health and economic systems. In this study we assessed the death rate associated to COVID-19 in Brazil and the United States of America (USA) to estimate the probability of Brazil becoming the next pandemic epicenter. We equated data between Brazil and USA obtained through the Worldometer website (www.worldometer.info). Epidemic curves from Brazil and USA were associated and regression analysis was undertaken to predict the Brazilian death rate regarding COVID-19 in June. In view of data from April 9th 2020, death rates in Brazil follow a similar exponential increase to USA (r=0.999; p<0.001), estimating 64,310 deaths by June 9th 2020. In brief, our results demonstrated that Brazil follows an analogous progression of COVID-19 deaths cases when compared to USA, signifying that Brazil could be the next global epicenter of COVID-19. We highlight public strategies to decrease the COVID-19 outbreak.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot appliedClinical Protocols http://www.worldometer.info Funding StatementAuthors thank the technical staff from Sao Paulo State University, UNESP/Marilia, SP, Brazil and University of Health Sciences of Alagoas, AL, Brazil. Dr. Vitor receives financial support from FAPESP (Process number 2012/01366-6) financial support from the National Council for Scientific and Technological Development, an entity linked to the Ministry of Science, Technology, Innovations and Communications from Brazil (Process number 302197/2018-4).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available at www.worldometer.info http://www.worldometer.info